triptolide has been researched along with Osteolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, JM; Ihn, HJ; Kim, JA; Kim, SH; Kim, SY; Lim, J; Park, EK; Park, JY; Shin, HI | 1 |
| Ang, ES; Chim, SM; Ding, Y; Feng, H; Huang, J; Liu, Q; Pavlos, N; Tan, RX; Tickner, J; Wu, H; Xu, J; Xue, W; Ye, J; Zhao, J; Zhou, L | 1 |
2 other study(ies) available for triptolide and Osteolysis
| Article | Year |
|---|---|
Inhibitory effects of triptolide on titanium particle-induced osteolysis and receptor activator of nuclear factor-κB ligand-mediated osteoclast differentiation.
Topics: Acid Phosphatase; Animals; Blotting, Western; Cell Differentiation; Cell Survival; Diterpenes; Epoxy Compounds; Isoenzymes; Macrophages; Male; Mice; Mice, Inbred ICR; Osteoclasts; Osteolysis; Phenanthrenes; Receptor Activator of Nuclear Factor-kappa B; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tartrate-Resistant Acid Phosphatase; Titanium | 2015 |
Triptolide inhibits osteoclast formation, bone resorption, RANKL-mediated NF-қB activation and titanium particle-induced osteolysis in a mouse model.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line; Diterpenes; Epoxy Compounds; Mice; Osteoclasts; Osteolysis; Phenanthrenes; RANK Ligand; Titanium; Transcription Factor RelA | 2015 |